← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2009Last known activity
Oct 21, 2024
Timeline
2000s
- Jun 1, 2008
Guangzhou Pharmaceucal Company Limited— Founded
Drugs by trial phase (22 distinct, 15 trials)
Phase 4 (7 own, 0 via acquisition)
Phase 3 (8 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Recent trials (15)
- NCT06611345Lead sponsorN/AOct 21, 2024
- NCT06613373Lead sponsorPhase 4Oct 15, 2024
- NCT06353360Lead sponsorPhase 2Apr 30, 2024
- NCT05661240Lead sponsorPhase 2/Phase 3Dec 20, 2022
- NCT05653453Lead sponsorPhase 3Dec 20, 2022
- NCT05305456Lead sponsorPhase 3Mar 28, 2022
- NCT04812236Lead sponsorPhase 4Apr 1, 2021
- NCT04509323Lead sponsorPhase 4Aug 3, 2020
- NCT04261920Lead sponsorPhase 4Jan 3, 2020
- NCT03616444Lead sponsorPhase 4Aug 19, 2018
- NCT03745261CollaboratorPhase 3Jun 20, 2018
- NCT03264794Lead sponsorPhase 4Aug 31, 2017
- NCT03016832Lead sponsorEarly Phase 1Jan 1, 2017
- NCT02993419Lead sponsorPhase 4Dec 1, 2016
- NCT01189656CollaboratorPhase 2Jan 1, 2009
Details
- Founded
- Guangzhou, CN Jun 1, 2008
- Last known activity
- Oct 21, 2024